8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Edwards Lifesciences filed an 8‑K (Item 9.01) on Jan 12, 2026 — Exhibit 99.1: Press Release dated Jan 9,…
Filed with the SEC on · Summarized by InvestorsBot
Edwards Lifesciences filed an 8‑K (Item 9.01) on Jan 12, 2026 — Exhibit 99.1: Press Release dated Jan 9, 2026; Exhibit 104: Inline XBRL cover page. Investors should read Exhibit 99.1 for any material updates. 🗂️ $EW #8K #SECfiling
Form signed Jan 9, 2026 by Mark D. Peterson, Corporate VP & General Counsel. No other financial statements listed in Item 9.01 — check the attached press release for specifics before trading. ✍️ $EW #MedTech #Edwards